Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Corentec Co Ltd Receives Approval from CFDA


Tuesday, 24 Sep 2013 08:27pm EDT 

Corentec Co Ltd announced that it has received an approval from China Food and Drug Administration (CFDA) for its total knee replacement products, on September 16, 2013. 

Company Quote

35.6
0.22 +0.62%
10:36am EST